Tranexamic Acid

トラネキサム酸

Brightening (美白) quasi-drug strong evidence

What It Does

A powerhouse brightening ingredient originally developed in Japan. Blocks melanin production at the source for visibly more even skin tone.

Tranexamic acid is one of Japan's most trusted brightening ingredients, with decades of clinical use behind it. Originally developed as a medication to control bleeding, Japanese researchers discovered its remarkable ability to inhibit melanin production when applied topically. The breakthrough came when Daiichi Sankyo identified its skin lightening properties, leading to widespread adoption in Japanese skincare.

It works by suppressing inflammation-induced melanin production, specifically by blocking plasmin activity and the keratinocyte-melanocyte signaling pathway. This prevents dark spots before they form rather than just fading existing pigmentation. Clinical studies show it is particularly effective for melasma and sun-induced hyperpigmentation.

In Japan, tranexamic acid holds quasi-drug status, meaning its efficacy for brightening is officially recognized by the Pharmaceutical and Medical Device Agency (PMDA). You will find it in many of Japan's most popular brightening serums, lotions, and spot treatments, often at concentrations of 2 to 3 percent.

How It Works

Blocks plasmin activity and suppresses cytokines that stimulate melanin production. Prevents the interaction between keratinocytes and melanocytes that triggers pigment formation.

The Japanese Context

Developed and patented for skincare use in Japan. Holds quasi-drug status with officially recognized brightening efficacy. One of the most prescribed and trusted brightening ingredients in Japanese dermatology.